Bio Historical Balance Sheet

TECH Stock

USD 76.02 0.66 0.88%

Trend analysis of Bio Techne Corp balance sheet accounts such as Total Stockholder Equity of 2.2 B, Property Plant And Equipment Net of 359.6 M, Net Debt of 281.1 M or Retained Earnings of 1.4 B provides information on Bio Techne's total assets, liabilities, and equity, which is the actual value of Bio Techne Corp to its prevalent stockholders. By breaking down trends over time using Bio Techne balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bio Techne Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bio Techne Corp is a good buy for the upcoming year.

Bio Techne Inventory

188.72 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Bio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bio Techne Corp at a specified time, usually calculated after every quarter, six months, or one year. Bio Techne Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bio Techne and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bio currently owns. An asset can also be divided into two categories, current and non-current.

Bio Techne Balance Sheet Chart

As of now, Bio Techne's Total Current Liabilities is increasing as compared to previous years. The Bio Techne's current Total Stockholder Equity is estimated to increase to about 2.2 B, while Cash is projected to decrease to under 89.5 M.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Treasury Stock

Add Fundamental

Total Assets

Total assets refers to the total amount of Bio Techne assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bio Techne Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Bio Techne balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bio Techne Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Bio Techne's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bio Techne Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	326.0M	455.0M	419.5M	440.5M
Total Assets	2.3B	2.6B	2.7B	2.8B

Short Long Term Debt Total Total Assets

Bio Techne balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Property Plant And Equipment Gross	Common Stock Total Equity	Short Term Investments
Total Assets		0.9	0.66	0.93	0.98	0.96	0.74	0.98	0.25	0.99	0.29	0.07	0.97	0.93	0.87	0.97	0.9	0.95	0.91	0.87	0.85	0.5	0.9	0.86	0.71	-0.38
Short Long Term Debt Total	0.9		0.46	0.86	0.79	0.76	0.93	0.83	0.06	0.92	0.19	-0.09	0.84	0.76	0.99	0.81	0.75	0.75	0.99	0.65	0.7	0.73	0.96	0.64	0.49	-0.35
Other Current Liab	0.66	0.46		0.81	0.68	0.69	0.33	0.6	0.23	0.64	0.0	0.12	0.68	0.63	0.44	0.66	0.6	0.71	0.53	0.64	0.71	-0.03	0.48	0.67	0.54	-0.22
Total Current Liabilities	0.93	0.86	0.81		0.89	0.88	0.74	0.87	0.18	0.93	0.04	0.02	0.91	0.86	0.85	0.88	0.81	0.88	0.9	0.78	0.87	0.47	0.88	0.78	0.57	-0.34
Total Stockholder Equity	0.98	0.79	0.68	0.89		0.99	0.62	0.98	0.31	0.96	0.34	0.13	0.97	0.94	0.76	0.99	0.92	0.97	0.81	0.91	0.85	0.36	0.8	0.91	0.79	-0.37
Property Plant And Equipment Net	0.96	0.76	0.69	0.88	0.99		0.59	0.96	0.32	0.94	0.35	0.13	0.94	0.92	0.73	0.97	0.91	0.98	0.78	0.9	0.89	0.3	0.78	0.91	0.77	-0.37
Net Debt	0.74	0.93	0.33	0.74	0.62	0.59		0.65	-0.3	0.81	0.12	-0.4	0.72	0.55	0.93	0.66	0.62	0.6	0.91	0.37	0.52	0.74	0.89	0.51	0.4	-0.37
Retained Earnings	0.98	0.83	0.6	0.87	0.98	0.96	0.65		0.33	0.96	0.3	0.17	0.94	0.96	0.81	0.95	0.88	0.91	0.84	0.91	0.79	0.5	0.85	0.85	0.71	-0.31
Cash	0.25	0.06	0.23	0.18	0.31	0.32	-0.3	0.33		0.15	0.18	0.85	0.15	0.39	0.07	0.22	0.17	0.24	0.09	0.61	0.36	-0.08	0.1	0.16	0.08	0.11
Non Current Assets Total	0.99	0.92	0.64	0.93	0.96	0.94	0.81	0.96	0.15		0.28	-0.04	0.97	0.9	0.9	0.96	0.9	0.93	0.93	0.81	0.83	0.54	0.93	0.85	0.7	-0.44
Non Currrent Assets Other	0.29	0.19	0.0	0.04	0.34	0.35	0.12	0.3	0.18	0.28		0.01	0.28	0.2	0.16	0.37	0.27	0.36	0.13	0.28	0.17	-0.23	0.12	0.24	0.51	-0.24
Cash And Short Term Investments	0.07	-0.09	0.12	0.02	0.13	0.13	-0.4	0.17	0.85	-0.04	0.01		-0.07	0.3	-0.09	0.01	-0.05	0.03	-0.07	0.51	0.2	-0.11	-0.09	-0.04	-0.13	0.6
Net Receivables	0.97	0.84	0.68	0.91	0.97	0.94	0.72	0.94	0.15	0.97	0.28	-0.07		0.88	0.8	0.98	0.93	0.96	0.85	0.82	0.79	0.43	0.84	0.9	0.8	-0.49
Common Stock Shares Outstanding	0.93	0.76	0.63	0.86	0.94	0.92	0.55	0.96	0.39	0.9	0.2	0.3	0.88		0.74	0.89	0.79	0.87	0.79	0.92	0.83	0.44	0.81	0.79	0.6	-0.17
Non Current Liabilities Total	0.87	0.99	0.44	0.85	0.76	0.73	0.93	0.81	0.07	0.9	0.16	-0.09	0.8	0.74		0.77	0.7	0.7	0.99	0.62	0.68	0.76	0.98	0.58	0.42	-0.34
Inventory	0.97	0.81	0.66	0.88	0.99	0.97	0.66	0.95	0.22	0.96	0.37	0.01	0.98	0.89	0.77		0.94	0.99	0.81	0.86	0.84	0.35	0.8	0.92	0.82	-0.44
Other Current Assets	0.9	0.75	0.6	0.81	0.92	0.91	0.62	0.88	0.17	0.9	0.27	-0.05	0.93	0.79	0.7	0.94		0.94	0.74	0.8	0.74	0.37	0.71	0.96	0.86	-0.5
Other Stockholder Equity	0.95	0.75	0.71	0.88	0.97	0.98	0.6	0.91	0.24	0.93	0.36	0.03	0.96	0.87	0.7	0.99	0.94		0.76	0.86	0.87	0.24	0.74	0.94	0.83	-0.44
Total Liab	0.91	0.99	0.53	0.9	0.81	0.78	0.91	0.84	0.09	0.93	0.13	-0.07	0.85	0.79	0.99	0.81	0.74	0.76		0.67	0.74	0.72	0.98	0.64	0.46	-0.35
Total Current Assets	0.87	0.65	0.64	0.78	0.91	0.9	0.37	0.91	0.61	0.81	0.28	0.51	0.82	0.92	0.62	0.86	0.8	0.86	0.67		0.8	0.28	0.65	0.78	0.65	-0.09
Short Term Debt	0.85	0.7	0.71	0.87	0.85	0.89	0.52	0.79	0.36	0.83	0.17	0.2	0.79	0.83	0.68	0.84	0.74	0.87	0.74	0.8		0.2	0.75	0.73	0.47	-0.25
Accounts Payable	0.5	0.73	-0.03	0.47	0.36	0.3	0.74	0.5	-0.08	0.54	-0.23	-0.11	0.43	0.44	0.76	0.35	0.37	0.24	0.72	0.28	0.2		0.74	0.21	0.04	-0.14
Intangible Assets	0.9	0.96	0.48	0.88	0.8	0.78	0.89	0.85	0.1	0.93	0.12	-0.09	0.84	0.81	0.98	0.8	0.71	0.74	0.98	0.65	0.75	0.74		0.62	0.41	-0.39
Property Plant And Equipment Gross	0.86	0.64	0.67	0.78	0.91	0.91	0.51	0.85	0.16	0.85	0.24	-0.04	0.9	0.79	0.58	0.92	0.96	0.94	0.64	0.78	0.73	0.21	0.62		0.89	-0.47
Common Stock Total Equity	0.71	0.49	0.54	0.57	0.79	0.77	0.4	0.71	0.08	0.7	0.51	-0.13	0.8	0.6	0.42	0.82	0.86	0.83	0.46	0.65	0.47	0.04	0.41	0.89		-0.51
Short Term Investments	-0.38	-0.35	-0.22	-0.34	-0.37	-0.37	-0.37	-0.31	0.11	-0.44	-0.24	0.6	-0.49	-0.17	-0.34	-0.44	-0.5	-0.44	-0.35	-0.09	-0.25	-0.14	-0.39	-0.47	-0.51

Click cells to compare fundamentals

Bio Techne Account Relationship Matchups

Bio Techne balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0B	2.3B	2.3B	2.6B	2.7B	2.8B
Short Long Term Debt Total	433.5M	420.6M	326.0M	455.0M	419.5M	440.5M
Other Current Liab	8.3M	62.9M	69.2M	45.3M	63.9M	67.1M
Total Current Liabilities	106.7M	152.3M	176.0M	128.5M	159.4M	167.3M
Total Stockholder Equity	1.4B	1.6B	1.7B	2.0B	2.1B	2.2B
Property Plant And Equipment Net	248.3M	281.7M	288.8M	324.5M	342.4M	359.6M
Net Debt	286.9M	221.5M	153.4M	274.4M	267.7M	281.1M
Retained Earnings	1.1B	1.1B	1.1B	1.3B	1.3B	1.4B
Cash	146.6M	199.1M	172.6M	180.6M	151.8M	89.5M
Non Current Assets Total	1.5B	1.8B	1.7B	2.0B	2.1B	2.2B
Non Currrent Assets Other	13.5M	11.6M	(88.2M)	285.3M	12.1M	16.3M
Cash And Short Term Investments	270.9M	231.6M	247.0M	204.3M	152.9M	137.1M
Net Receivables	122.5M	145.4M	194.5M	218.5M	241.4M	253.5M
Common Stock Shares Outstanding	157.6M	161.9M	164.1M	161.9M	160.8M	169.2M
Liabilities And Stockholders Equity	2.0B	2.3B	2.3B	2.6B	2.7B	2.8B
Non Current Liabilities Total	539.7M	539.4M	417.8M	543.7M	475.6M	499.4M
Inventory	103.2M	116.7M	141.1M	171.6M	179.7M	188.7M
Other Current Assets	24.3M	16.9M	22.9M	27.1M	43.4M	45.6M
Other Stockholder Equity	420.5M	534.4M	653.7M	721.5M	820.3M	861.4M
Total Liab	646.4M	691.7M	593.8M	672.2M	635.0M	666.8M
Total Current Assets	520.9M	510.6M	605.6M	621.5M	617.4M	648.3M
Short Term Debt	22.0M	35.7M	36.4M	22.4M	25.8M	27.1M
Accounts Payable	63.3M	29.4M	33.9M	25.7M	38.0M	39.9M
Intangible Assets	516.5M	616.0M	531.5M	534.6M	507.1M	532.4M
Property Plant And Equipment Gross	248.3M	281.7M	288.8M	324.5M	599.0M	628.9M
Accumulated Other Comprehensive Income	(97.2M)	(57.3M)	(75.2M)	(66.1M)	(78.3M)	(74.4M)
Common Stock Total Equity	385K	390K	392K	1.6M	1.8M	1.9M
Short Term Investments	124.3M	32.5M	74.5M	23.7M	1.1M	1.0M
Common Stock	385K	390K	392K	1.6M	1.6M	1.7M
Other Liab	110.9M	143.0M	116.2M	99.9M	114.9M	97.2M
Other Assets	13.5M	11.6M	46.8M	12.6M	14.5M	8.8M
Long Term Debt	344.2M	328.8M	243.4M	350M	319M	335.0M
Property Plant Equipment	248.3M	281.7M	288.8M	226.2M	260.1M	139.9M
Good Will	728.3M	843.1M	822.1M	872.7M	972.7M	1.0B
Current Deferred Revenue	13.0M	19.0M	23.4M	23.1M	27.9M	29.3M
Net Tangible Assets	136.3M	112.2M	347.4M	652.9M	587.6M	617.0M
Retained Earnings Total Equity	1.1B	1.1B	1.1B	1.3B	1.5B	812.3M
Capital Surpluse	420.5M	534.4M	653.7M	721.5M	829.8M	871.3M
Deferred Long Term Liab	101.1M	93.1M	99.0M	89.0M	102.3M	67.5M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Techne's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.32)

Dividend Share

0.32

Earnings Share

0.95

Revenue Per Share

7.424

Quarterly Revenue Growth

0.045

The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Historical Balance Sheet

Bio Techne Inventory

188.72 Million

About Bio Balance Sheet Analysis

Bio Techne Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Bio Techne balance sheet Correlations

Bio Techne Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bio Techne balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Net	+ 0.99	Total Stockholder Equity
Inventory	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.99	Non Current Liabilities Total

Short Term Investments	- 0.51	Common Stock Total Equity
Short Term Investments	- 0.5	Other Current Assets
Short Term Investments	- 0.49	Net Receivables
Short Term Investments	- 0.47	Property Plant And Equipment Gross
Short Term Investments	- 0.44	Other Stockholder Equity
Short Term Investments	- 0.44	Inventory